CWEN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CWEN is not a strong buy right now for a Beginner long-term investor with $50,000-$100,000 available. The company has solid long-term renewable power growth prospects and improving analyst targets, but the current technical setup is weak, the latest quarter missed EPS badly, and there is no Intellectia buy signal to prioritize. My direct view: hold and wait for a cleaner entry rather than buying immediately.
Current price is 38.50, slightly above support at 38.178 and below the pivot at 39.615. MACD histogram is -0.19 and still negatively expanding, which points to short-term downside momentum. RSI_6 at 38.17 is neutral-to-weak, not oversold enough to signal a clear rebound. Moving averages are converging, suggesting compression but not a confirmed uptrend. Overall trend is mixed to weak, with near-term support at 37.291 and resistance at 41.051/41.938.
Revenue in Q1 grew 18.8% year over year to $354 million and beat expectations. The late-stage pipeline expanded to 12.7 GW, with funding secured for Honeycomb Phase I and 500 MW of power purchase agreements signed. Analysts have been raising price targets overall, with Morgan Stanley, UBS, RBC, Roth Capital, and Deutsche Bank all recently maintaining positive or constructive ratings. The broader demand backdrop from AI data centers and electricity growth remains supportive for long-term renewable infrastructure names.
Q1 GAAP EPS missed expectations by $0.88, which is a notable earnings disappointment. Net income fell to 0 year over year, and the stock is trading below its pivot level with negative MACD momentum. The latest price action is also weaker than the broader market session, and options volume is tilted strongly toward puts. There is no AI Stock Picker signal and no recent SwingMax buy signal.
Latest quarter: Q1 2026. Revenue increased 18.79% year over year to $354 million, which is a strong top-line result. Gross margin improved to 10.73, also a positive trend. However, net income dropped to 0 and GAAP EPS came in at -$1.35, missing expectations significantly. The financial picture shows growth in revenue and project pipeline strength, but earnings quality for the quarter was weak.
Analyst sentiment remains constructive overall. Recent targets moved higher from multiple firms: Morgan Stanley raised PT to $56 and kept Overweight; UBS raised to $44 and kept Buy; RBC raised to $42 and kept Outperform; Roth raised to $45 and kept Buy. Deutsche Bank was slightly more cautious, trimming PT to $41 but keeping Buy, while Evercore was neutral with an In Line rating and PT raised to $39. Wall Street pros are broadly positive on long-term growth and visibility, but the near-term earnings miss keeps the case from being a strong immediate buy.
